Acute Leukemia News

• Cognitive Decline Risk in Adult Childhood Cancer Survivors All cancers survivors, regardless of therapy, should be regularly screened for new-onset neurocognitive problems "decades" after diagnosis, researchers say.
  Medscape Medical News, June 07, 2023
• Patient With Blood Cancer Takes on Bias and 'Gaslighting' After having her concerns dismissed by her doctor, a woman diagnosed with Hodgkin lymphoma partnered with the Lymphoma Research Foundation to spread the word about unique challenges facing patients.
  MDedge News, June 01, 2023
• ASCO 2023 'Paradigm Shift': Luspatercept for MDS Luspatercept showed significant improvement over erythropoiesis-stimulating agent epoetin alfa in reducing dependency on red blood cell transfusions in patients with LR-MDS who are ESA naive.
  MDedge News, June 01, 2023
• ASCO 2023 Cross-Border US–Mexican Collaboration Drives Up ALL Survival A close collaboration between hospitals across the US–Mexican border improved survival for children with acute lymphoblastic leukemia (ALL), underlining the power of shared knowledge and skills, say researchers.
  Medscape Medical News, May 25, 2023
• Hagop Kantarjian, MD, Honored by ASCO for Leukemia Research Kantarjian receives the highest honor from the American Society of Clinical Oncology (ASCO) for his lifelong contributions to leukemia research and patient care.
  Medscape Medical News, May 15, 2023
• Phase 3 Trial: Maribavir Yields Post-Transplant Benefits Maribavir may reduce mortality risk among patients with resistant or refractory post-transplant CMV infection following hematopoietic stem cell and solid organ transplant.
  MDedge News, May 08, 2023
• 'Terrific Progress': Adding Blinatumomab for Infant Leukemia The immunotherapy plus standard chemotherapy improved short-term outcomes for infants with acute lymphoblastic leukemia.
  MDedge News, May 04, 2023
• Healthy Lifestyle Mitigates Impact of Childhood Cancer Survivors of childhood cancer who follow a healthy lifestyle may substantially reduce excess risk of later mortality from causes such as cancer and cardiovascular disease, suggests a new analysis.
  Medscape Medical News, April 10, 2023
• Advanced Leukemia Novel Drug Leads to 'Impressive' Responses The experimental menin inhibitor revumenib led to "deep and sustained remission" for two genetic subtypes of aggressive relapsed/refractory acute leukemia in the first-in-human trial.
  Medscape Medical News, March 20, 2023
• Venetoclax Shows Promise for R/R Hairy Cell Leukemia Five of six patients with relapsed or refractory hairy cell leukemia experienced a response to venetoclax alone or in combination with rituximab.
  Medscape Medical News, March 09, 2023
• First Prospective Study of TKI Ponatinib Shows Benefit in Ph+ALL The study findings add new insights, but also raise new questions, about the best treatment approach for Philadelphia chromosome-positive acute lymphoblastic leukemia.
  Medscape Medical News, March 03, 2023
• Maternal Infection in Pregnancy Ups Risk for Childhood Leukemia? Maternal urinary and genital tract infections during pregnancy appear to markedly increase the risk for leukemia in offspring, warn researchers in a large-scale analysis of Danish registry data.
  Medscape Medical News, February 20, 2023
• GUCS 2023 Talazoparib Add-On Improves Outcomes in Metastatic Prostate Cancer For patients with metastatic castration-resistant prostate cancer, talazoparib combined with enzalutamide achieved better progression-free survival than enzalutamide alone.
  Medscape Medical News, February 17, 2023
• Similar Survival Observed After Transplantation vs Chemo in AML Although transplantation and consolidation chemo in intermediate-risk patients led to similar overall survival outcomes, outside experts note that the results may not translate to real-life practice.
  Medscape Medical News, February 17, 2023
• GUCS 2023 Rucaparib Benefit in BRCA+ Prostate Cancer Confirmed For patients with metastatic castration-resistant prostate cancer with BRCA alterations, rucaparib doubled progression-free survival as compared with docetaxel, abiraterone, or enzalutamide.
  Medscape Medical News, February 17, 2023
• How Medicare Could Save $1.29 Billion a Year on Urology Drugs Medicare could save more than $1 billion each year just on urology drugs by using Mark Cuban's cost-plus drug pricing model, new findings suggest.
  Medscape Medical News, February 15, 2023
• Cardioprotection for 20 Years for Children With Cancer A case is building for the routine use of dexrazoxane to protect the hearts of children with cancer being treated with doxorubicin.
  Medscape Medical News, January 31, 2023
• Blood Test 24 Hours After Starting Chemo Predicts AML Survival Protein changes in peripheral blood samples in the first 24 hours after starting chemotherapy could predict which patients with acute myeloid leukemia respond.
  Medscape Medical News, January 18, 2023
• Congenital CMV Linked to Pediatric Hyperdiploid ALL Early congenital cytomegalovirus could be a modifiable risk factor for childhood hyperdiploid acute lymphoblastic leukemia but more research delineating a mechanism is warranted.
  Medscape Medical News, January 13, 2023
• New Trials in Leukemia and Lymphoma: Could Your Patient Benefit? Could one of your patients benefit from the latest clinical trials enrolling patients with leukemia or lymphoma?
  Medscape Medical News, January 09, 2023